Aurobindo Pharma Ltd AUROPHARMA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹1,515.30
- Day Range
- ₹1,489.65–1,520.85
- 52-Week Range
- ₹834.65–1,592.00
- Bid/Ask
- ₹1,511.35 / ₹1,511.35
- Market Cap
- ₹877.79 Bil
- Volume/Avg
- 704,353 / 1.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- 24.76
- Price/Sales
- 3.02
- Dividend Yield (Trailing)
- 0.30%
- Dividend Yield (Forward)
- 0.30%
- Total Yield
- 0.30%
Company Profile
Aurobindo Pharma Ltd is a specialty and generic drug manufacturing company. It is principally engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Its formulations target key therapeutic areas, including Central Nervous System (CNS), Antibiotics, Anti-diabetics, Cardiovascular, Anti-retroviral, Gastroenterology, Oncology, and Dermatology. The operating and reportable segments of the company are; India, the United States of America, Europe, and the Rest of the World. The company generates a majority of its revenue from its business in the United States of America.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Growth
- Total Number of Employees
- 37,596
- Website
- https://www.aurobindo.com
Comparables
Valuation
|
Metric
|
AUROPHARMA
|
MARKSANS
|
532815
|
|---|---|---|---|
Price/Earnings (Normalized) | 24.76 | 41.61 | 52.55 |
Price/Book Value | 2.98 | 6.71 | 5.91 |
Price/Sales | 3.02 | 6.12 | 4.08 |
Price/Cash Flow | 23.01 | 39.40 | 36.20 |
Price/Earnings
AUROPHARMA
MARKSANS
532815
Financial Strength
|
Metric
|
AUROPHARMA
|
MARKSANS
|
532815
|
|---|---|---|---|
Quick Ratio | 0.96 | 2.99 | 0.86 |
Current Ratio | 1.98 | 4.78 | 1.61 |
Interest Coverage | 15.28 | 33.90 | 4.55 |
Quick Ratio
AUROPHARMA
MARKSANS
532815
Profitability
|
Metric
|
AUROPHARMA
|
MARKSANS
|
532815
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
AUROPHARMA
MARKSANS
532815
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Jncymvnbfc | Wfvnh | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Wfpmjjqv | Ppqlqnz | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Hqrjdjnb | Xkfp | $48.4 Bil | |||
| Viatris Inc
VTRS
| Dzpxsgxz | Byjs | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Jmqfhxk | Fmjq | $13.5 Bil | |||
| Catalent Inc
CTLT
| Czgznlkq | Ffbrfbs | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Ctxbzpld | Hbqxxmg | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Mgcphgq | Dsyl | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Qtsvxvwr | Qsmy | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Yxdlcrld | Nclpb | $2.3 Bil |
United States